Pathstone Holdings »

Lexicon Pharmaceuticals shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2024-12-31 $40k 54k 0.74
2024-09-30 $93k 59k 1.57
2024-06-30 $101k 60k 1.68
2024-03-31 $151k 63k 2.40
2023-12-31 $53k 34k 1.53

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Crowdstrike Hldgs Cl A (CRWD)
Ishares Tr Core S&p Mcp Etf (IJH)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Large Cap Etf (VV)
Coca-Cola Company (KO)

View all positions for Pathstone Holdings

Top funds holding Lexicon Pharmaceuticals

Artal Group
FMR
Siren
BlackRock
Vanguard Group
Point72 Asset Management
Schonfeld Strategic Advisors
Nantahala Capital Management
Geode Capital Management
State Street Corporation
NEA Management Company
Ikarian Capital
Gail Mannix
Northern Trust
Charles Schwab Investment Management

View all funds holding Lexicon Pharmaceuticals